Young-onset acromegaly and gigantism: Causes and clinical features of growth hormone overproduction

Authors

  • Raquel Vaz de Castro Serviço de Endocrinologia, Diabetes e Metabolismo Hospital de Santa Maria, CHULN – EPE, Lisboa https://orcid.org/0000-0002-9113-8114
  • Joana Faustino epartment of Pediatrics, Hospital Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central https://orcid.org/0000-0003-4015-5624
  • Florbela Ferreira Department of Endocrinology, Diabetes and Metabolism, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte
  • Lurdes Sampaio Pediatric Endocrinology Unit, Department of Pediatrics Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte https://orcid.org/0000-0003-3026-9820

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v32.i2.26186

Keywords:

acromegaly, gigantism, cause, clinical feature

Abstract

Depending on the age of onset, the excessive release of growth hormone (GH) − most commonly by a pituitary tumor − and subsequently of insulin-like growth factor 1 (IGF1) can cause acromegaly and gigantism.
The purpose of this study was to describe the clinical manifestations and main known causes of GH overproduction.
GH-releasing hormone and IGF1 can result in a series of physical traits and comorbidities due to hormonal imbalance and somatic overgrowth. To date, several syndromes and genetic mutations have been linked to the etiology of acromegaly.

Downloads

Download data is not yet available.

References

Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, et al. Acromegaly. Nat Rev Dis Primers 2019; 5(1):20. doi: https://doi.org/10.1038/s41472-019-0071-6.

Rostomyan L, Daly AF, Beckers A. Pituitary gigantism: Causes and clinical characteristics. Ann Endocrinol (Paris) 2015;76(6):643-9; doi: https://doi.org/10.1016/j.ando.2015.10.002.

Gadelha MR, Ksuki L, Korbonits M. The genetic background of acromegaly. Pituitary. 2017;20(1):10-21; doi: https://doi.org/10.1007/s11102-017-0789-7.

Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA,Beckers A. High prevalence of pituitary adenomas: across- sectional study in the province of Liege, Belgium. J ClinEndocrinol Metab 2006; 91(12):4769–75. doi: https://doi.org/10.1210/jc.2006-1668.

Kwon O, Song YD, Kim SY, Lee EJ Rare Disease Study Group,Science and Research Committee, Korean Endocrine Society, Nationwide survey of acromegaly in South Korea. ClinEndocrinol (Oxf) 2013; 78(4):577–85. doi: https://doi.org/10.1111/cen.12020.

Holdaway IM, Rajasoorya C, Epidemiology of acromegaly. Pituitary 1999; 2(1):29–41. doi: https://doi.org/10.1023/a:1009965803750.

Nabarro JD. Acromegaly. Clin Endocrinol 1987; 26(4):481–512.

Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol 2010; 72(2):203–8. doi: https://doi.org/10.1111/j.1365-2265.2009.03626.x.

Melmed S. Medical progress: Acromegaly . N Engl J Med 2006; 355(24): 2558–73. doi: https://doi.org/10.1056/NEJMra062453.

Molitch ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 1992; 21(3):597–614.

Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis 2008; 3:17. doi: https://doi.org/10.1186/1750-1172-3-17.

Katznelson L., Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: An Endocrine Society Clinical Practice Guideline. JCEM 2014; 99(11):3933-51. doi: https://doi.org/10.1210/jc.2014-2700. doi:10.1210/jc.2014-2700.

Salenave S, Boyce AM, Collins MT, Chanson P. Acromegaly and McCune-Albright Syndrome. JCEM 2014; 99(6):1955-69. doi: https://doi.org/10.1210/jc.2013-3826.

Schöfl C, Honegger J, Droste M, Grussendorf M, Finke R, Plöckinger U, et al. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study. JCEM 2014; 99(12):E2789-E2793. doi: 10.1210/jc.2014-2094. doi: https://doi.org/10.1210/jc.2014-2094.

Beckers A, Rostomyan L, Potorac I, Beckers P, Daly AF. X-LAG: How did they grow so tall? Ann Endocrinol (Paris) 2017; 78(2):131-6. doi: https://doi.org/10.1016/j.ando.2017.04.013.

Sargent J. X-linked acrogigantism – genetic characterization of a newly described paediatric growth disorder. Nat Rev Endocrinol 2015; 11(2):64. doi: https://doi.org/10.1038/nrendo.2014.230.

Gadelha M.R., Kasuki L., Korbonits M. The genetic background of acromegaly. Pituitary. 2017;20:10–21. doi: https://doi.org/10.1007/s11102-017-0789-7.

Downloads

Published

2023-09-14

How to Cite

1.
Vaz de Castro R, Faustino J, Ferreira F, Sampaio L. Young-onset acromegaly and gigantism: Causes and clinical features of growth hormone overproduction. REVNEC [Internet]. 2023Sep.14 [cited 2024May4];32(2):103-7. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/26186

Issue

Vol. 32 No. 2 (2023)

Section

Review Articles

License

Copyright (c) 2023 Raquel Vaz de Castro, Joana Faustino, Florbela Ferreira, Lurdes Sampaio

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright and access

This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.

Most read articles by the same author(s)